First-in-Class Phosphorylated-p68 Inhibitor RX-5902 Inhibits β-Catenin Signaling and Demonstrates Antitumor Activity in Triple-Negative Breast Cancer. https://t.co/isnYO0PXGK https://t.co/MAEV8z9Grg
1,319 followers
1,926 followers
RT @MCT_AACR: First-in-Class Phosphorylated-p68 Inhibitor RX-5902 Inhibits β-Catenin Signaling and Demonstrates Antitumor Activity in Tripl…
1,319 followers
First-in-Class Phosphorylated-p68 Inhibitor RX-5902 Inhibits β-Catenin Signaling and Demonstrates Antitumor Activity in Triple-Negative Breast Cancer. https://t.co/zOsl4AnWSP https://t.co/YPj3Kl83Jz
1,319 followers
First-in-Class Phosphorylated-p68 Inhibitor RX-5902 Inhibits β-Catenin Signaling and Demonstrates Antitumor Activity in Triple-Negative Breast Cancer. https://t.co/fl4knOBU9W https://t.co/5CFIV2ykSU